{
  "symbol": "GILD",
  "year": 2023,
  "Period": "Q1",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": 0.0,
    "outlook_sentiment": 0.0978,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.338
  },
  "top_positive": [
    {
      "sent": "The following table summarizes the classification and fair values of derivative instruments, including the potential effect of offsetting: September 30, 2023 Derivative Assets Derivative Liabilities (in millions) Classification Fair Value Classification Fair Value Derivatives designated as hedges: Foreign currency exchange contracts Prepaid and other current assets $ 57 Other current liabilities $ 7 Foreign currency exchange contracts Other long-term assets 10 Other long-term obligations \u2014 Total derivatives designated as hedges 67 7 Derivatives not designated as hedges: Foreign currency exchange contracts Prepaid and other current assets \u2014 Other current liabilities 1 Total derivatives not designated as hedges \u2014 1 Total derivatives presented gross on the Condensed Consolidated Balance Sheets $ 67 $ 8 Gross amounts not offset on the Condensed Consolidated Balance Sheets: Derivative financial instruments ( 8 ) ( 8 ) Cash collateral received / pledged \u2014 \u2014 Net amount (legal offset) $ 59 $ \u2014 17 December 31, 2022 Derivative Assets Derivative Liabilities (in millions) Classification Fair Value Classification Fair Value Derivatives designated as hedges: Foreign currency exchange contracts Prepaid and other current assets $ 59 Other current liabilities $ 26 Foreign currency exchange contracts Other long-term assets 1 Other long-term obligations 9 Total derivatives designated as hedges 59 35 Derivatives not designated as hedges: Foreign currency exchange contracts Prepaid and other current assets 1 Other current liabilities 7 Total derivatives not designated as hedges 1 7 Total derivatives presented gross on the Condensed Consolidated Balance Sheets $ 60 $ 42 Gross amounts not offset on the Condensed Consolidated Balance Sheets: Derivative financial instruments ( 36 ) ( 36 ) Cash collateral received / pledged \u2014 \u2014 Net amount (legal offset) $ 25 $ 7 The following table summarizes the effect of our derivative contracts on our Condensed Consolidated Financial Statements: Three Months Ended Nine Months Ended September 30, September 30, (in millions) 2023 2022 2023 2022 Derivatives designated as hedges: \neptember 30, 2023 (in millions) Amortized\u00a0Cost Fair Value Within one year $ 1,233 $ 1,226 After one year through five years 1,161 1,147 After five years through ten years 6 6 After ten years 3 3 Total $ 2,403 $ 2,382 15 Equity Securities Equity Securities Measured at Fair Value The following table summarizes the classification of our equity securities measured at fair value on a recurring basis, on our Condensed Consolidated Balance Sheets: (in millions) September 30, 2023 December 31, 2022 Cash and cash equivalents $ 4,240 $ 3,831 Prepaid and other current assets (1) 1,110 473 Other long-term assets (1) 244 943 Total $ 5,594 $ 5,248 ________________________________ (1) Includes our equity method investments in Arcus and Galapagos, for which we elected and applied the fair value option as we believe it best reflects the underlying economics of these investments.",
      "score": 0.9891
    },
    {
      "sent": "49 Exhibit Index Exhibit Footnote Exhibit Number Description of Document (1) 3.1 Restated Certificate of Incorporation of Registrant (2) 3.2 Amended and Restated Bylaws of Registrant 4.1 Reference is made to Exhibit 3.1 and Exhibit 3.2 (3) 4.2 Indenture related to Senior Notes, dated as of March\u00a030, 2011, between Registrant and Wells Fargo, National Association, as Trustee (3) 4.3 First Supplemental Indenture related to Senior Notes, dated as of March 30, 2011, between Registrant and Wells Fargo, National Association, as Trustee (including form of Senior Notes) (4) 4.4 Second Supplemental Indenture related to Senior Notes, dated as of December 13, 2011, between Registrant and Wells Fargo, National Association, as Trustee (including Form of 2041 Note) (5) 4.5 Third Supplemental Indenture related to Senior Notes, dated as of March 7, 2014, between Registrant and Wells Fargo, National Association, as Trustee (including Form of 2024 Note and Form of 2044 Note) (6) 4.6 Fourth Supplemental Indenture related to Senior Notes, dated as of November 17, 2014, between Registrant and Wells Fargo, National Association, as Trustee (including Form of 2025 Note and Form of 2045 Note) (7) 4.7 Fifth Supplemental Indenture, dated as of September 14, 2015, between Registrant and Wells Fargo Bank, National Association, as Trustee (including Form of 2026 Note, Form of 2035 Note and Form of 2046 Note) (8) 4.8 Sixth Supplemental Indenture, dated as of September 20, 2016, between Registrant and Wells Fargo Bank, National Association, as Trustee (including Form of 2027 Note, Form of 2036 Note and Form of 2047 Note) (9) 4.9 Eighth Supplemental Indenture, dated as of September 30, 2020, between the Registrant and Wells Fargo Bank, National Association, as Trustee (including Form of 2027 Note, Form of 2030 Note, Form of 2040 Note, and Form of 2050 Note ) (10) 4.1 Ninth Supplemental Indenture, dated as of September 14, 2023, between the Registrant and Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National Association, as Trustee (including Form of 2033 Note and Form of 2053 Note ) (11) 4.10 Description of Registrant\u2019s Securities (12) 10.1* Gilead Sciences, Inc.",
      "score": 0.9858
    },
    {
      "sent": "The following table summarizes the classification of our available-for-sale debt securities in our Condensed Consolidated Balance Sheets: (in millions) September 30, 2023 December 31, 2022 Cash and cash equivalents $ 67 $ 75 Short-term marketable debt securities 1,159 973 Long-term marketable debt securities 1,156 1,245 Total $ 2,382 $ 2,293 The following table summarizes our available-for-sale debt securities by contractual maturity: September 30, 2023 (in millions) Amortized\u00a0Cost Fair Value Within one year $ 1,233 $ 1,226 After one year through five years 1,161 1,147 After five years through ten years 6 6 After ten years 3 3 Total $ 2,403 $ 2,382 15 Equity Securities Equity Securities Measured at Fair Value The following table summarizes the classification of our equity securities measured at fair value on a recurring basis, on our Condensed Consolidated Balance Sheets: (in millions) September 30, 2023 December 31, 2022 Cash and cash equivalents $ 4,240 $ 3,831 Prepaid and other current assets (1) 1,110 473 Other long-term assets (1) 244 943 Total $ 5,594 $ 5,248 ________________________________ (1) Includes our equity method investments in Arcus and Galapagos, for which we elected and applied the fair value option as we believe it best reflects the underlying economics of these investments.",
      "score": 0.979
    }
  ],
  "top_negative": [
    {
      "sent": "Problems with any of the single suppliers or facilities we depend on, including in the event of a disaster, such as an earthquake, equipment failure or other difficulty, may negatively impact our development and commercialization efforts.",
      "score": -0.91
    },
    {
      "sent": "Problems with any of the single suppliers or facilities we depend on, including in the event of a disaster, such as an earthquake, equipment failure or other difficulty, may negatively impact our development and commercialization efforts.",
      "score": -0.91
    },
    {
      "sent": "Problems with any of the single suppliers or facilities we depend on, including in the event of a disaster, such as an earthquake, equipment failure or other difficulty, may negatively impact our development and commercialization efforts.",
      "score": -0.91
    }
  ],
  "forward_snippets": [
    "We believe this presentation assists users of the financial statements to better understand cash flow movements.",
    "We do not currently intend to sell, and it is not more likely than not that we will be required to sell, such investments before recovery of their amortized cost bases.",
    "The following table summarizes the classification of our available-for-sale debt securities in our Condensed Consolidated Balance Sheets: (in millions) September 30, 2023 December 31, 2022 Cash and cash equivalents $ 67 $ 75 Short-term marketable debt securities 1,159 973 Long-term marketable debt securities 1,156 1,245 Total $ 2,382 $ 2,293 The following table summarizes our available-for-sale debt securities by contractual maturity: September 30, 2023 (in millions) Amortized\u00a0Cost Fair Value Within one year $ 1,233 $ 1,226 After one year through five years 1,161 1,147 After five years through ten years 6 6 After ten years 3 3 Total $ 2,403 $ 2,382 15 Equity Securities Equity Securities Measured at Fair Value The following table summarizes the classification of our equity securities measured at fair value on a recurring basis, on our Condensed Consolidated Balance Sheets: (in millions) September 30, 2023 December 31, 2022 Cash and cash equivalents $ 4,240 $ 3,831 Prepaid and other current assets (1) 1,110 473 Other long-term assets (1) 244 943 Total $ 5,594 $ 5,248 ________________________________ (1) Includes our equity method investments in Arcus and Galapagos, for which we elected and applied the fair value option as we believe it best reflects the underlying economics of these investments.",
    "The following table summarizes the classification and fair values of derivative instruments, including the potential effect of offsetting: September 30, 2023 Derivative Assets Derivative Liabilities (in millions) Classification Fair Value Classification Fair Value Derivatives designated as hedges: Foreign currency exchange contracts Prepaid and other current assets $ 57 Other current liabilities $ 7 Foreign currency exchange contracts Other long-term assets 10 Other long-term obligations \u2014 Total derivatives designated as hedges 67 7 Derivatives not designated as hedges: Foreign currency exchange contracts Prepaid and other current assets \u2014 Other current liabilities 1 Total derivatives not designated as hedges \u2014 1 Total derivatives presented gross on the Condensed Consolidated Balance Sheets $ 67 $ 8 Gross amounts not offset on the Condensed Consolidated Balance Sheets: Derivative financial instruments ( 8 ) ( 8 ) Cash collateral received / pledged \u2014 \u2014 Net amount (legal offset) $ 59 $ \u2014 17 December 31, 2022 Derivative Assets Derivative Liabilities (in millions) Classification Fair Value Classification Fair Value Derivatives designated as hedges: Foreign currency exchange contracts Prepaid and other current assets $ 59 Other current liabilities $ 26 Foreign currency exchange contracts Other long-term assets 1 Other long-term obligations 9 Total derivatives designated as hedges 59 35 Derivatives not designated as hedges: Foreign currency exchange contracts Prepaid and other current assets 1 Other current liabilities 7 Total derivatives not designated as hedges 1 7 Total derivatives presented gross on the Condensed Consolidated Balance Sheets $ 60 $ 42 Gross amounts not offset on the Condensed Consolidated Balance Sheets: Derivative financial instruments ( 36 ) ( 36 ) Cash collateral received / pledged \u2014 \u2014 Net amount (legal offset) $ 25 $ 7 The following table summarizes the effect of our derivative contracts on our Condensed Consolidated Financial Statements: Three Months Ended Nine Months Ended September 30, September 30, (in millions) 2023 2022 2023 2022 Derivatives designated as hedges: \neptember 30, 2023 (in millions) Amortized\u00a0Cost Fair Value Within one year $ 1,233 $ 1,226 After one year through five years 1,161 1,147 After five years through ten years 6 6 After ten years 3 3 Total $ 2,403 $ 2,382 15 Equity Securities Equity Securities Measured at Fair Value The following table summarizes the classification of our equity securities measured at fair value on a recurring basis, on our Condensed Consolidated Balance Sheets: (in millions) September 30, 2023 December 31, 2022 Cash and cash equivalents $ 4,240 $ 3,831 Prepaid and other current assets (1) 1,110 473 Other long-term assets (1) 244 943 Total $ 5,594 $ 5,248 ________________________________ (1) Includes our equity method investments in Arcus and Galapagos, for which we elected and applied the fair value option as we believe it best reflects the underlying economics of these investments.",
    "Outside the U.S., we will commercialize the product and Arcellx will receive royalties on sales."
  ]
}